Diabetes Foot Africa Region Registry

NCT ID: NCT07031141

Last Updated: 2025-06-22

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Total Enrollment

2000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-08-01

Study Completion Date

2027-02-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

D-FAR is to gather robust data on the clinical characteristics, management, and outcomes of patients with diabetic foot complications to enhance understanding, reduce complications, and improve patient care. This will include insights into the prevalence of risk factors, adherence to treatment protocols, and the effectiveness of interventions aimed at reducing the incidence of amputations and other adverse outcomes.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Among the various complications, those related to diabetic foot disease are associated with the highest morbidity and mortality. Diabetic foot problems are characterized by infection, ulceration and/or destruction of deep tissue in the foot and are usually associated with neurological abnormalities and varying degrees of peripheral arterial disease (PAD) in the lower limb. the purpose of collect comprehensive data on the clinical features, management strategies, and outcomes of patients with diabetic foot complications.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Diabetes

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Male and female patients
2. Residents of participating African countries.
3. Diagnosed with diabetic foot complications (e.g., ulcers, gangrene, infection, ischemia).
4. Patients with a history of foot ulcers or amputations due to diabetes.
5. High-risk patients with peripheral neuropathy and/or peripheral arterial disease.

Exclusion Criteria

1. Non-diabetic foot complications.
2. Acute traumatic injuries unrelated to diabetes.
3. Patients unwilling to provide informed consent.
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Getz Pharma

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Zulfiqarali G Abbas, MBBS, MMed, DTM&H

Role: PRINCIPAL_INVESTIGATOR

D-Foot International

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Muhammad Nabeed Tahir, MBBS

Role: CONTACT

+9230153762 ext. 2907

Arsalan arif, MBBS

Role: CONTACT

+923120279179

References

Explore related publications, articles, or registry entries linked to this study.

Abbas ZG, Boulton AJM. Diabetic foot ulcer disease in African continent: 'From clinical care to implementation' - Review of diabetic foot in last 60 years - 1960 to 2020. Diabetes Res Clin Pract. 2022 Jan;183:109155. doi: 10.1016/j.diabres.2021.109155. Epub 2021 Nov 24.

Reference Type BACKGROUND
PMID: 34838640 (View on PubMed)

Naemi R, Chockalingam N, Lutale JK, Abbas ZG. Predicting the risk of future diabetic foot ulcer occurrence: a prospective cohort study of patients with diabetes in Tanzania. BMJ Open Diabetes Res Care. 2020 May;8(1):e001122. doi: 10.1136/bmjdrc-2019-001122.

Reference Type BACKGROUND
PMID: 32371531 (View on PubMed)

Bak JCG, Serne EH, Kramer MHH, Nieuwdorp M, Verheugt CL. National diabetes registries: do they make a difference? Acta Diabetol. 2021 Mar;58(3):267-278. doi: 10.1007/s00592-020-01576-8. Epub 2020 Aug 8.

Reference Type BACKGROUND
PMID: 32770407 (View on PubMed)

Related Links

Access external resources that provide additional context or updates about the study.

http://iwgdfguidelines.org/guidelines-2019/

ocuses on strategies to prevent foot ulcers, including patient education, regular foot examinations, and appropriate footwear.Provides recommendations on relieving pressure (offloading) from foot ulcers to promote healing.

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

GETZ-DF-01-24

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Beta Cell Function in (Pre) Type 1 Diabetes
NCT00800085 UNKNOWN PHASE1/PHASE2